1.
Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy
by Gilbert, Richard E, Prof
The Lancet (British edition), 2015, Vol.385 (9982), p.2107-2117
2.
Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study
by Krum, Henry, Prof
The Lancet (British edition), 2014, Vol.383 (9917), p.622-629
3.
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis
by Kotecha, Dipak, Dr
The Lancet (British edition), 2014, Vol.384 (9961), p.2235-2243
4.
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
by Krum, Henry, Prof
The Lancet (British edition), 2009, Vol.373 (9671), p.1275-1281
5.
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis
by Phrommintikul, Arintaya, MD
The Lancet (British edition), 2007, Vol.369 (9559), p.381-388
7.
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
by Weber, Michael A, Prof
The Lancet (British edition), 2009, Vol.374 (9699), p.1423-1431
8.
Medical therapy for chronic heart failure
by Krum, Henry, Prof
The Lancet (British edition), 2011, Vol.378 (9792), p.713-721
9.
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review
by Chow, Clara K, Prof
The Lancet (British edition), 2017, Vol.389 (10073), p.1035-1042
